Author
Listed:
- Byung-Hoon Lee
(Harvard Medical School)
- Min Jae Lee
(Harvard Medical School)
- Soyeon Park
(Harvard Medical School)
- Dong-Chan Oh
(Harvard Medical School
Natural Products Research Institute, College of Pharmacy, Seoul National University, San 56-1, Sillim, Seoul 151-742, Republic of Korea)
- Suzanne Elsasser
(Harvard Medical School)
- Ping-Chung Chen
(Evelyn F. McKnight Brain Institute, Civitan International Research Center, University of Alabama at Birmingham)
- Carlos Gartner
(Harvard Medical School
Present addresses: Department of Biological Sciences, 193 Galvin Life Sciences Center, Notre Dame, Indiana 46556, USA (C.G.); Department of Pathology, Brigham and Women's Hospital, 75 Francis Street, Boston, Massachusetts 02115, USA (J.H.).)
- Nevena Dimova
(Harvard Medical School)
- John Hanna
(Harvard Medical School
Present addresses: Department of Biological Sciences, 193 Galvin Life Sciences Center, Notre Dame, Indiana 46556, USA (C.G.); Department of Pathology, Brigham and Women's Hospital, 75 Francis Street, Boston, Massachusetts 02115, USA (J.H.).)
- Steven P. Gygi
(Harvard Medical School)
- Scott M. Wilson
(Evelyn F. McKnight Brain Institute, Civitan International Research Center, University of Alabama at Birmingham)
- Randall W. King
(Harvard Medical School)
- Daniel Finley
(Harvard Medical School)
Abstract
Proteasomes, the primary mediators of ubiquitin–protein conjugate degradation, are regulated through complex and poorly understood mechanisms. Here we show that USP14, a proteasome-associated deubiquitinating enzyme, can inhibit the degradation of ubiquitin–protein conjugates both in vitro and in cells. A catalytically inactive variant of USP14 has reduced inhibitory activity, indicating that inhibition is mediated by trimming of the ubiquitin chain on the substrate. A high-throughput screen identified a selective small-molecule inhibitor of the deubiquitinating activity of human USP14. Treatment of cultured cells with this compound enhanced degradation of several proteasome substrates that have been implicated in neurodegenerative disease. USP14 inhibition accelerated the degradation of oxidized proteins and enhanced resistance to oxidative stress. Enhancement of proteasome activity through inhibition of USP14 may offer a strategy to reduce the levels of aberrant proteins in cells under proteotoxic stress.
Suggested Citation
Byung-Hoon Lee & Min Jae Lee & Soyeon Park & Dong-Chan Oh & Suzanne Elsasser & Ping-Chung Chen & Carlos Gartner & Nevena Dimova & John Hanna & Steven P. Gygi & Scott M. Wilson & Randall W. King & Dani, 2010.
"Enhancement of proteasome activity by a small-molecule inhibitor of USP14,"
Nature, Nature, vol. 467(7312), pages 179-184, September.
Handle:
RePEc:nat:nature:v:467:y:2010:i:7312:d:10.1038_nature09299
DOI: 10.1038/nature09299
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Citations
Citations are extracted by the
CitEc Project, subscribe to its
RSS feed for this item.
Cited by:
- Ka Ying Sharon Hung & Sven Klumpe & Markus R. Eisele & Suzanne Elsasser & Geng Tian & Shuangwu Sun & Jamie A. Moroco & Tat Cheung Cheng & Tapan Joshi & Timo Seibel & Duco Dalen & Xin-Hua Feng & Ying L, 2022.
"Allosteric control of Ubp6 and the proteasome via a bidirectional switch,"
Nature Communications, Nature, vol. 13(1), pages 1-13, December.
- Dongni Shi & Xianqiu Wu & Yunting Jian & Junye Wang & Chengmei Huang & Shuang Mo & Yue Li & Fengtian Li & Chao Zhang & Dongsheng Zhang & Huizhong Zhang & Huilin Huang & Xin Chen & Y. Alan Wang & Chuyo, 2022.
"USP14 promotes tryptophan metabolism and immune suppression by stabilizing IDO1 in colorectal cancer,"
Nature Communications, Nature, vol. 13(1), pages 1-18, December.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:467:y:2010:i:7312:d:10.1038_nature09299. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.